Title |
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults
|
---|---|
Published in |
European Journal of Clinical Pharmacology, December 2013
|
DOI | 10.1007/s00228-013-1613-6 |
Pubmed ID | |
Authors |
Juha Puustinen, Ritva Lähteenmäki, Päivi Polo-Kantola, Paula Salo, Tero Vahlberg, Alan Lyles, Pertti J. Neuvonen, Markku Partinen, Ismo Räihä, Sirkka-Liisa Kivelä |
Abstract |
The aim of this study was to assess the effect of withdrawal from the long-term use of temazepam, zopiclone or zolpidem as hypnotics drugs (here referred to as BZD) on cognitive performance. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 33% |
Japan | 3 | 25% |
Spain | 1 | 8% |
Unknown | 4 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 75% |
Practitioners (doctors, other healthcare professionals) | 3 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 66 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 13% |
Student > Bachelor | 8 | 12% |
Student > Ph. D. Student | 7 | 10% |
Other | 6 | 9% |
Researcher | 6 | 9% |
Other | 18 | 26% |
Unknown | 15 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 23% |
Nursing and Health Professions | 9 | 13% |
Psychology | 9 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
Agricultural and Biological Sciences | 3 | 4% |
Other | 6 | 9% |
Unknown | 19 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2015.
All research outputs
#2,758,712
of 23,866,543 outputs
Outputs from European Journal of Clinical Pharmacology
#206
of 2,623 outputs
Outputs of similar age
#32,312
of 313,078 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#2
of 27 outputs
Altmetric has tracked 23,866,543 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,623 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.